ICD-10 Coding for Papillary Thyroid Cancer(C77.0, C77.0B, C77.0C)
Comprehensive guide on ICD-10 coding for papillary thyroid cancer, including documentation requirements and common pitfalls.
Complete code families applicable to Papillary Thyroid Cancer
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C73 | Malignant neoplasm of thyroid gland | Use when papillary thyroid carcinoma is confirmed without metastasis. |
|
| C77.0 | Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | Use when papillary thyroid carcinoma has metastasized to cervical lymph nodes. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutPapillary Thyroid Cancer
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Papillary Thyroid Cancer.
Coding C73 without histological confirmation
Impact
Clinical: May lead to inappropriate treatment decisions., Regulatory: Non-compliance with coding standards., Financial: Potential for claim denials.
Mitigation
Verify histological confirmation before coding., Ensure documentation includes pathology report.
Using C73 without histological confirmation
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data and statistics.
Mitigation
Ensure histological confirmation before coding C73.
Histological confirmation
Impact
Coding C73 without confirmed histology increases audit risk.
Mitigation
Ensure all cases have documented histological confirmation.
Frequently Asked Questions
Primary Code
Malignant neoplasm of thyroid glandC73Secondary and unspecified malignant neoplasm of lymph nodes of head, face and nec